@kimmellor.bsky.social
🫀 Our new study published this week in Nature Cardiovascular Research identifies a promising new therapeutic target for diabetic heart disease.
🔗 rdcu.be/eIEN4
Funded by HRC & @marsdenfund.bsky.social
🔗 rdcu.be/eIEN4
Funded by HRC & @marsdenfund.bsky.social
Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues
Nature Cardiovascular Research - Mellor et al. report that deficiency of GABARAPL1, an ATG8-specific linking protein, impairs diastolic function in diabetic mice. This effect can be reversed by...
rdcu.be
October 1, 2025 at 4:58 AM
🫀 Our new study published this week in Nature Cardiovascular Research identifies a promising new therapeutic target for diabetic heart disease.
🔗 rdcu.be/eIEN4
Funded by HRC & @marsdenfund.bsky.social
🔗 rdcu.be/eIEN4
Funded by HRC & @marsdenfund.bsky.social